V
STJ

Veritable’s St Jude Medical STJ Stock Holding History

Veritable’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,403
Closed -$834K – 773
2016
Q4 		$834K Buy
10,403
+91
+0.9% +$7.22K 0.02% 348
2016
Q3 		$822K Buy
10,312
+2,342
+29% +$189K 0.02% 359
2016
Q2 		$622K Buy
7,970
+1,329
+20% +$94.8K 0.02% 393
2016
Q1 		$365K Buy
6,641
+141
+2% +$7.68K 0.01% 512
2015
Q4 		$402K Sell
6,500
-742
-10% -$46.8K 0.01% 518
2015
Q3 		$457K Buy
7,242
+1,767
+32% +$126K 0.01% 472
2015
Q2 		$400K Sell
5,475
-2,585
-32% -$187K 0.01% 523
2015
Q1 		$527K Buy
8,060
+169
+2% +$11.2K 0.01% 592
2014
Q4 		$513K Sell
7,891
-61
-0.8% -$3.93K 0.01% 595
2014
Q3 		$478K Buy
7,952
+22
+0.3% +$1.44K 0.01% 620
2014
Q2 		$549K Sell
7,930
-403
-5% -$26.1K 0.01% 576
2014
Q1 		$545K Buy
8,333
+2,726
+49% +$177K 0.01% 566
2013
Q4 		$347K Sell
5,607
-8,798
-61% -$509K 0.01% 673
2013
Q3 		$773K Buy
14,405
+4,150
+40% +$214K 0.02% 449
2013
Q2 		$468K Buy
+10,255
New +$444K 0.01% 596

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Veritable's STJ Position: Q1 2017 in Review

Veritable sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 10,403 shares — an estimated $834K sold.

Veritable first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $834K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Veritable reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Veritable sold 10,403 St Jude Medical shares in Q1 2017, an estimated $834K.
  • Veritable first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Veritable's St Jude Medical position peaked at $834K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Veritable's 13F filing for Q1 2017, filed 15 May 2017.